Skip to main content
Fig. 3 | European Radiology Experimental

Fig. 3

From: Variability of noninvasive MRI and biological markers in compensated cirrhosis: insights for assessing disease progression

Fig. 3

a Year-to-year percentage change in clinical measures in the stable compensated cirrhosis control group. b Year-to-year coefficient of variation (CoVT) in clinical measures in the stable compensated cirrhosis control group. Clinical measures of MELD, UKELD, APRI, FIB4, ELF scores, and Fibroscan® LSM are shown. Bars indicate the interquartile range and the horizontal bold line shows the median, dots represent outliers. MELD Model for end-stage liver disease, UKELD United Kingdom model for end-stage liver disease, APRI Aspartate aminotransferase to platelet ratio index, FIB4 Fibrosis-4, ELF Enhanced liver fibrosis, LSM Liver stiffness measure

Back to article page